Las Vegas, NV, Oct. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Grey Cloak Tech Inc (OTC: GRCK): Effective on September 24, 2019, Sanjeev Javia resigned as our Chief Executive Officer, President, and as a member of our Board of Directors. Kevin Pitts, our Chief Operating Officer, was immediately appointed as our President to replace Mr. Javia, and Bill Croyle was immediately appointed as a member of our Board of Directors to replace Mr. Javia. In addition, to further round out our management group, the Company created the BergaMet Scientific and Athletic Advisory Board.
Sanjeev Javia will be heading up the BergaMet Scientific and Athletic Advisory Board, which will include top Physicians in the country focusing on the benefits of the BergaMet bergamot SuperFruit.
Mr. Pitts states, “We are excited about this restructuring as it allows BergaMet NA to optimize upper management talents for sales, marketing and operations.” The change comes after evaluating the operations since the acquisition of Bergamet NA in February 2019. Mr. Pitts also stated, “We have been aggressive in our sales and operation efforts and are working on a number of exciting marketing opportunities to grow the company.”
Bill Croyle’s vast knowledge and experience in business will complement Grey Cloak Tech’s existing Board of Directors. Bill Croyle, age 67, is a private investor and an accomplished Senior Executive with over 40 years of success in the IT, energy, manufacturing, telecommunications, venture capital, and finance industries. His broad areas of expertise include mergers and acquisitions, negotiations, service contracts and delivery, executive development and mentoring, and managing complexities. Since 2009 Bill has been a founder, owner or executive of EnTX Group, Impact Legacy Partners, FB Oilfield Special Tools and Western Energy Advisors.
BergaMet NA imports, manufactures and distributes a proprietary line of products that is clinically shown to have beneficial uses that support and promote cholesterol, cardiovascular, and metabolic health. BergaMet is only grown in the Southern Region of Reggio Calabria derived from the rare citrus fruit called “Bergamot” and is referred to as a “superfruit” because of the unusual composition of the various antioxidant polyphenols. BergaMet’s extract has the highest quality and concentration available of Bergamot anywhere in the world. It’s a naturally sourced organic supplement with no side effects.
BergaMet’s products can be found at www.bergametna.com, on Amazon, and other online retailers.
About Grey Cloak Tech, Inc. The Company, through its subsidiaries, is engaged in the sale and distribution of full spectrum hemp oil, and the full line of BergaMet products. BergaMet’s products can be found at www.bergametna.com, on Amazon, and other online retailers.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility," and "anticipate." The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties, and assumptions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors set forth in the Company's Annual Report on Form 10-K filed with the SEC on April 17, 2017 and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.
For more information, visit http://www.greycloaktech.com, http://bergametna.com